Title : Simvastatin decreases myocardial tumor necrosis factor alpha content in heart transplant recipients.

Pub. Date : 2005 Jan

PMID : 15653378






6 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Simvastatin decreases myocardial tumor necrosis factor alpha content in heart transplant recipients. Simvastatin tumor necrosis factor Homo sapiens
2 We studied the effects of simvastatin treatment on myocardial tumor necrosis factor alpha (TNF-alpha) expression; TNF-alpha is a potent pro-inflammatory cytokine associated with hypertrophy and fibrosis in heart transplant recipients. Simvastatin tumor necrosis factor Homo sapiens
3 We studied the effects of simvastatin treatment on myocardial tumor necrosis factor alpha (TNF-alpha) expression; TNF-alpha is a potent pro-inflammatory cytokine associated with hypertrophy and fibrosis in heart transplant recipients. Simvastatin tumor necrosis factor Homo sapiens
4 We studied the effects of simvastatin treatment on myocardial tumor necrosis factor alpha (TNF-alpha) expression; TNF-alpha is a potent pro-inflammatory cytokine associated with hypertrophy and fibrosis in heart transplant recipients. Simvastatin tumor necrosis factor Homo sapiens
5 At the 24(th) week after transplantation, when compared with Week 1 values, we found a significant decrease in myocardium TNF-alpha content in the simvastatin group (15.0% +/- 2.3% vs 5.8% +/- 2.4%, p = 0.02) that was not observed in the placebo group (15.0% +/- 1.5% vs 12.0% +/- 2.6%, p = not significant). Simvastatin tumor necrosis factor Homo sapiens
6 CONCLUSION: Simvastatin treatment in heart transplant recipients decreased myocardium TNF-alpha expression. Simvastatin tumor necrosis factor Homo sapiens